Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cellsBing Z. Carter, Michael Andreeff, Joel D. Leverson et al.|Science Translational Medicine|2016Cited by 172
Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimeticsBing Z. Carter, Michael Andreeff, Po Yee Mak et al.|Blood Cancer Journal|2023Cited by 33
Apoptosis repressor with caspase recruitment domain is regulated by MAPK/PI3K and confers drug resistance and survival advantage to AMLPo Yee Mak, B. Z. Carter, Duncan H. Mak et al.|APOPTOSIS|2013Cited by 27